In trading on Tuesday, the State Street SPDR S&P Biotech ETF is outperforming other ETFs, up about 3.5% on the day. Components of that ETF showing particular strength include shares of Myriad Genetics, up about 37.5% and shares of Sagimet Biosciences, up about 12.4% on the
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。